News Beckley Canopy Therapeutics raises £7.4m for cannabis R&D Oxford-based biopharma Beckley Canopy Therapeutics has raised £7.4 million to develop a range of cannabis-based products for the treatment of pain and to help tackle
News Trump signs legislation to tackle opiate addiction President Donald Trump has signed new legislation into law that he hopes will “end the scourge” of addiction to opiates in the US.
News Teva holding off launch of opioid addiction drug Drugmaker awaiting outcome of separate court case
News FDA approves Indivior's long-lasting opioid withdrawal thera... Monthly injection will help addicts manage withdrawal symptoms
News Summit climbs on rumour of $15bn AstraZeneca interest Is AstraZeneca about to join the ranks of pharma companies spending big bucks on PD(L)-1xVEGF bispecific antibodies for cancer?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face